These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 20185635)

  • 1. Suppressors of cytokine signaling abrogate diabetic nephropathy.
    Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy.
    Shi Y; Du C; Zhang Y; Ren Y; Hao J; Zhao S; Yao F; Duan H
    Am J Nephrol; 2010; 31(5):380-8. PubMed ID: 20299783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy.
    Zhou Y; Lv C; Wu C; Chen F; Shao Y; Wang Q
    Acta Histochem; 2014 Jun; 116(5):981-8. PubMed ID: 24802166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
    Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
    Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new pair of SOCS for diabetic nephropathy.
    Brosius FC; Banes-Berceli A
    J Am Soc Nephrol; 2010 May; 21(5):723-4. PubMed ID: 20413610
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy.
    Hu J; Fan X; Meng X; Wang Y; Liang Q; Luo G
    Planta Med; 2014 Jun; 80(8-9):614-21. PubMed ID: 24853762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway.
    Liu Y; Zhang M; Zeng L; Lai Y; Wu S; Su X
    Mol Med; 2024 Jun; 30(1):78. PubMed ID: 38844873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
    Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response.
    Kundu K; Dutta K; Nazmi A; Basu A
    Cell Immunol; 2013; 285(1-2):100-10. PubMed ID: 24140964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
    Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
    Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
    PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.
    Liu Q; Xing L; Wang L; Yao F; Liu S; Hao J; Liu W; Duan H
    J Histochem Cytochem; 2014 Feb; 62(2):119-28. PubMed ID: 24217922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition.
    Lopez-Sanz L; Bernal S; Recio C; Lazaro I; Oguiza A; Melgar A; Jimenez-Castilla L; Egido J; Gomez-Guerrero C
    Lab Invest; 2018 Oct; 98(10):1276-1290. PubMed ID: 29540859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK inhibition and progressive kidney disease.
    Brosius FC; He JC
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):88-95. PubMed ID: 25415616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
    Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.
    Kopalli SR; Annamneedi VP; Koppula S
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
    Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
    Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.
    Liang Y; Jin Y; Li Y
    Pediatr Nephrol; 2009 Sep; 24(9):1661-71. PubMed ID: 19350281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.